Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Press Release|Articles|August 6, 2026
Upcoming NCPA Events for Pharmacy Teams: August 2026
Listen
0:00 / 0:00
Key Takeaways
- An Aug. 13 Learning Hour will train pharmacy teams to translate dispensing data into targeted patient outreach and DSMES enrollment workflows.
- A diabetes accreditation boot camp with an Aug. 24 registration deadline aims to prepare participants for DSMES accreditation within six weeks to support Medicare and payer reimbursement.
The NCPA is pleased to announce these upcoming online events for pharmacists and pharmacy team members.
Advertisement
ALEXANDRIA, Va. (Aug. 6, 2026) – The National Community Pharmacists Association is pleased to announce these upcoming online events for pharmacists and pharmacy team members:
- Aug. 13 – Data-Driven Diabetes Care: How to Turn Pharmacy Dispensing Data into DSMES Enrollment Opportunities, part of our NCPA Learning Hour series. Whether you’re just getting started or looking to grow your existing services, learn how to turn everyday dispensing data into actionable opportunities for patient outreach and diabetes self-management education enrollment.
Learn more and register.
- Aug. 24 – Registration deadline for the Diabetes Accreditation Boot Camp. The NCPA Innovation Center and PharmFurther offer this turnkey online course to help prepare participants for diabetes self-management education accreditation in six weeks or less so they can bill Medicare and other payers for diabetes education they’re probably already providing.
Learn more and register.
Ongoing:
- Encouraging community pharmacy teams to invite their federal representatives for a pharmacy visit during the August and October in-district work periods. Community pharmacy achieved a significant win this year, but there’s still more to accomplish. This important initiative will push for progress and keep community pharmacy on the minds of members of Congress.
Learn more and sign up to participate. - Registration is open for the Pre-Convention Growth and Profitability Programs being held in Kansas City, Mo., ahead of the NCPA 2026 Annual Convention. These courses will cover fundamentals of pharmacy ownership, real-world applications for artificial intelligence, long-term care pharmacy at home, and ways to advance existing LTC pharmacy services.
Learn more and register. - Registration is open for the NCPA 2026 Annual Convention and Expo. The convention, which will be held Oct. 3-6 in Kansas City, Mo., is the premier national business show for independent pharmacists and their teams.
Learn more and register.
Events are subject to change. Visit our website for the latest information on NCPA events.
Advertisement
Related to this article
Marie-Claire Seeley, RN, MNurs, PhD, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
A single infusion reversed new-onset type 1 diabetes (T1D) in more than half of treated mice by strengthening regulatory T cells and driving autoreactive CD8+ T cells into a less destructive state.
A detailed LINKER-MM1 analysis found that cytokine release syndrome (CRS) with linvoseltamab occurred early, was predominantly low grade, and became less frequent with successive step-up and full doses.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
Why 5 Injectable Drugs Have Been in Shortage for More Than a Decade
4
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
5